Editas Medicine
EDIT
#7713
Rank
NZ$0.80 B
Marketcap
NZ$5.26
Share price
1.47%
Change (1 day)
25.69%
Change (1 year)

Earnings for Editas Medicine (EDIT)

Earnings in 2026 (TTM): -NZ$0.18 Billion

According to Editas Medicine 's latest financial reports the company's current earnings are NZ$38.69 Million. In 2025 the company made an earning of -NZ$0.27 Billion, an increase over its 2024 earnings that were of -NZ$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Editas Medicine from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.18 Billion-32.71%
2025 -NZ$0.27 Billion-31.93%
2024 -NZ$0.39 Billion33.62%
2023 -NZ$0.29 Billion-25.13%
2022 -NZ$0.39 Billion16.98%
2021 -NZ$0.33 Billion43.24%
2020 -NZ$0.23 Billion-4.41%
2019 -NZ$0.24 Billion24.39%
2018 -NZ$0.2 Billion-4.98%
2017 -NZ$0.21 Billion22.73%
2016 -NZ$0.17 Billion172.88%
2015 -NZ$60.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-NZ$4.21 Million-97.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-NZ$0.13 Billion-29.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-NZ$0.11 Billion-37.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-NZ$0.26 Billion 43.15% Jersey